Time for Targeted PSA Screening for Men With Rare Pathogenic Variants?

(MedPage Today) -- Men with certain pathogenic variants had a higher incidence of prostate cancer versus age-matched controls, and may be candidates for targeted prostate-specific antigen (PSA) screening, according to findings from the IMPACT trial...